• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Tag­works lands $65M for its take on No­bel-win­ning click chem­istry in bid to ex­pand ADC, ra­dio­phar­ma po­ten­tial

3 years ago
Financing
Startups

Physi­cians rate Janssen, Mer­ck and No­vo Nordisk best for cus­tomer ex­pe­ri­ence in US — sur­vey

3 years ago
Pharma
Marketing

Brook­ings of­fers ideas on how to im­prove short­ages of ster­ile in­jecta­bles

3 years ago
Pharma
Manufacturing

Mod­er­na 'laser-fo­cused' on AI, from clin­i­cal de­vel­op­ment to mar­ket­ing: #Can­nes­Lions2023

3 years ago
AI
Pharma

Aldeyra suf­fers re­jec­tion in rare eye can­cer due to 'lack of sub­stan­tial ev­i­dence' but seeks use un­der Ex­pand­ed ...

3 years ago
Pharma
FDA+

FTC asks ap­peals court to re­verse de­ci­sion in po­ten­tial an­titrust case against Ab­b­Vie, gener­ic man­u­fac­tur­ers

3 years ago
Pharma

Lupin wins first FDA ap­proval for gener­ic ver­sion of Boehringer In­gel­heim block­buster Spiri­va

3 years ago
Pharma
FDA+

GSK dou­bles down on menin­gi­tis B aware­ness with new Life­time doc­u­men­tary host­ed by Soleil Moon Frye

3 years ago
Pharma
Marketing

Sau­di Ara­bia looks to boost bio­phar­ma in­ter­est with new con­tract man­u­fac­tur­er

3 years ago
Manufacturing

FDA+ roundup: Num­ber of drug sur­veil­lance in­spec­tions tripled from 2021 to 2022

3 years ago
FDA+

Trail­ing Akero and 89bio, Boston Phar­ma­ceu­ti­cals posts ear­ly da­ta on its NASH in­jec­tion

3 years ago
R&D

Saris­sa's Alk­er­mes board re­place­ments large­ly fail to win sup­port from share­hold­er firms, which cite Bio­gen board ...

3 years ago
People

UniQure un­veils mixed Hunt­ing­ton's gene ther­a­py da­ta, shares tank

3 years ago
R&D

Blue­bird gets PDU­FA date for lo­vo-cel; FDA lifts hold on Di­aMed­ica stroke tri­al

3 years ago
News Briefing

PhRMA joins Mer­ck and BMS in su­ing over Medicare drug price ne­go­ti­a­tions

3 years ago
Law

GSK, Pfiz­er present key dura­bil­i­ty da­ta for RSV shots, as CDC pan­el scru­ti­nizes ri­val vac­cines

3 years ago
R&D

Por­tal In­no­va­tions to call Hous­ton its third home, with CAR-T start­up March Bio­sciences al­ready in the port­fo­lio

3 years ago
Financing
Startups

As­traZeneca stops PhI­Ia tri­al of in­haled asth­ma drug with Pieris, cra­ter­ing the Boston biotech's shares

3 years ago
R&D

Ul­tragenyx opens new gene ther­a­py man­u­fac­tur­ing site in Mass­a­chu­setts

3 years ago
Cell/Gene Tx
Manufacturing

De­spite a dip in M&A val­ue and vol­ume, PwC pre­dicts deal ac­tiv­i­ty to re­main strong with an uptick in IPOs

3 years ago
Deals

Catal­ent names new CFO as con­tract man­u­fac­tur­er's ef­fort to right its op­er­a­tions con­tin­ues

3 years ago
People
Manufacturing

Art­bio emerges with $23M to make ra­di­oli­gand ther­a­pies for prostate can­cer, with field still in 'ear­ly days'

3 years ago
Financing
Startups

Flag­ship start­up Em­press Ther­a­peu­tics launch­es to search for small mol­e­cule drug leads in mi­cro­bial DNA

3 years ago
Financing
Startups

'On track to be­come a block­buster': FDA ap­proves in­jectable form of ar­genx's au­toim­mune drug

3 years ago
Pharma
FDA+
First page Previous page 323324325326327328329 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times